Keywords: Merck & Co, Enbel, Hanwha, Biosimilar, Amgen, Pfizer, Takeda

Merck & Co links with Korea’s Hanwha on biosimilar of Enbrel

Article | 14 June 2011

Print This

US drugs giant Merck & Co (NYSE:MRK) and South Korean drugmaker Hanwha Chemical Corp (KOSPI: 09830) have entered into an ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in